Table 4 Clinical trials of erythropoiesis-stimulating agents in predialysis chronic kidney disease patients
From: 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
| Â | Number | %DM | High Hb level group | Low Hb level group | ||||
|---|---|---|---|---|---|---|---|---|
Baseline | Target | Achieved | Baseline | Target | Achieved | |||
A21 2012 | 322 | 31 | 9.2 | 11–13 | 12 | 9.2 | 9–11 | 9.8 |
TREAT 2009 | 4038 | 100 | 10.5 | 13 | 12.5 | 10.4 | >9 (rescue) | 10.6 |
ACORD 2007 | 172 | 100 | 11.9 | 13–15 | 13.5 | 11.9 | 10.5–11.5 | 12.1 |
CREATE 2006 | 603 | 26 | 11.6 | 13–15 | 13.3 | 11.6 | 10.5–11.5 | 11.8 |
CHOIR 2006 | 1432 | 49 | 10.1 | 13.5 | 12.6 | 10.1 | 11.5 | 11.3 |
Gouva 2004 | 88 | 0 | 10.1 | >13 | 12.9 | 10.1 | >9 | 10.3 |
Kuriyama 1997 | 108 | Â | 9.3 | Treated | 11.8 | 9 | Untreated | 8.3 |